Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380978 · ClinicalTrials.gov registry record · NA
Neuraxial Versus Systemic Analgesia for Latent Phase Labor Effect on Rate of Operative Delivery
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 1,026
- Enrollment target
NCT00380978: Completed NA study, sponsored by Northwestern University.
NCT00380978 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 1,026 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00380978, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,026 participants
- Enrollment target
Study Summary
The purpose of this study in nulliparous women undergoing induction of labor is to determine whether initiation of neuraxial analgesia compared to systemic opioid analgesia early in labor (\< 4 cm cervical dilation)affects the cesarean delivery rate.
Primary Outcome
The decision to proceed to operative delivery was made by the obstetric team for maternal or fetal indications.
Interventions
- PROCEDURE combined spinal epidural analgesia
- PROCEDURE late analgesia (systemic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,026 participants |
| Start Date | 2001-10 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00380978 record still lists
NCT00380978 is an interventional study that assigns participants to a tested intervention. Its 1,026 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 2 interventions - of which combined spinal epidural analgesia is the first listed.
NCT00380978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00380978 about?
NCT00380978 is a clinical study titled "Neuraxial Versus Systemic Analgesia for Latent Phase Labor Effect on Rate of Operative Delivery". The purpose of this study in nulliparous women undergoing induction of labor is to determine whether initiation of neuraxial analgesia compared to systemic opioid analgesia early in labor (\< 4 cm cervical dilation)affects the cesarean delivery rate.
What is the current status of trial NCT00380978?
This trial is currently completed. It is a NA study. The enrollment target is 1,026 participants. The study started on 2001-10. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00380978?
The interventions under investigation include: combined spinal epidural analgesia (PROCEDURE), late analgesia (systemic) (PROCEDURE).
Who is sponsoring clinical trial NCT00380978?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00380978's enrollment target sits among peer trials
1,026 104th of 2000 higher than 1,897 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
- NCT07216703 · 1,023 participants · Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia